Indian perspective of remdesivir: A promising COVID-19 drug
- PMID: 32874008
- PMCID: PMC7446682
- DOI: 10.4103/ijp.IJP_486_20
Indian perspective of remdesivir: A promising COVID-19 drug
Conflict of interest statement
There are no conflicts of interest.
Comment on
-
A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3. Nature. 2020. PMID: 32015507 Free PMC article.
Similar articles
-
[Remdesivir for patients with COVID-19].Internist (Berl). 2020 Aug;61(8):869-872. doi: 10.1007/s00108-020-00836-7. Internist (Berl). 2020. PMID: 32572516 Free PMC article. German. No abstract available.
-
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6. Int J Antimicrob Agents. 2020. PMID: 32147516 Free PMC article. No abstract available.
-
Efficacy of Remdesivir in COVID-19.JAMA. 2020 Sep 15;324(11):1041-1042. doi: 10.1001/jama.2020.16337. JAMA. 2020. PMID: 32821934 No abstract available.
-
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217. J R Coll Physicians Edinb. 2020. PMID: 32568289 Review. No abstract available.
-
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.Eur J Med Chem. 2020 Sep 1;201:112527. doi: 10.1016/j.ejmech.2020.112527. Epub 2020 Jun 6. Eur J Med Chem. 2020. PMID: 32563812 Free PMC article. Review.
Cited by
-
Spinal Muscular Atrophy Therapeutics in India: Parental Hopes and Despair!Ann Neurosci. 2021 Jul;28(3-4):112-113. doi: 10.1177/09727531211046365. Epub 2021 Oct 3. Ann Neurosci. 2021. PMID: 35341234 Free PMC article. No abstract available.
-
Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database.BMC Infect Dis. 2022 Jan 4;22(1):1. doi: 10.1186/s12879-021-07004-8. BMC Infect Dis. 2022. PMID: 34983406 Free PMC article.
References
-
- Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19-Preliminary Report. N Engl J Med. 2020 In press. - PubMed
-
- Voluntary Licensing Agreements for Remdesivir. [Last accessed on 2020 May 20]. Available from: https://wwwgileadcom/purpose/advancing-global-health/covid-19/voluntary-... .
-
- FDA Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Remdesivir (gs-5734tm) [Last accessed on 2020 May 20]. Available from: https://wwwfdagov/media/137566/download .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources